caffeic acid phenethyl ester has been researched along with quercetin 3-o-glucopyranoside in 3 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (quercetin 3-o-glucopyranoside) | Trials (quercetin 3-o-glucopyranoside) | Recent Studies (post-2010) (quercetin 3-o-glucopyranoside) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 131 | 0 | 86 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | quercetin 3-o-glucopyranoside (IC50) |
|---|---|---|---|
| alkaline phosphatase, intestinal | Homo sapiens (human) | 7.105 | |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | Homo sapiens (human) | 14 | |
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 1.66 | |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 0.95 | |
| Arginase | Leishmania amazonensis | 2 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 4.4 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 4.5 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fallarero, A; Hanski, L; Isojärvi, J; Karhu, E; Vuorela, P | 1 |
3 other study(ies) available for caffeic acid phenethyl ester and quercetin 3-o-glucopyranoside
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Biological Products; Cell Line; Cell Survival; Chlamydophila pneumoniae; Drug Discovery; Humans; Ligands; Microbial Sensitivity Tests; Molecular Structure | 2017 |